Using Mass Cytometry to Profile Immune Signatures for Cancer Immunotherapy
Location:WMI, Level 2 Conference Facility
Dr Helen McGuire
NHMRC Postdoctoral Fellow, Tcell Biology Group, Centenary Institute for Cancer Medicine and Cell Biology and the Ramaciotti Facility for Human Systems Biology, University of Sydney
Helen McGuire is a NHMRC postdoctoral fellow, who returned at the start of 2015 from Stanford University, California. At Stanford, she was under the mentorship of Professor Mark Davis (Institute for Immunity Transplantation and Infection), a pioneering lab in the use of single cell proteomics technology know as Cytometry by Time-Of-Flight (CyTOF). Helen has combined the use of CyTOF and MHC tetramer technology to characterize immune responses following vaccination and viral infection in clinical samples. Helen has joined Prof Barbara Fazekas and the Ramaciotti Facility for Human Systems Biology, launching mass cytometry onto the Australian medical research scene. Of particular interest is using the mass cytometry platform to profile immune signatures in cancer and therapeutic intervention.